Cargando…

Hypoxia and tumour angiogenesis involved in breast cancer progression and targets for therapy

Detalles Bibliográficos
Autor principal:	Harris, AL
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2000
Materias:	Speaker Presentations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300887/ http://dx.doi.org/10.1186/bcr189

Ejemplares similares

Target versus non-target lesions in determining disease progression: analysis of 545 patients
por: Raskin, S, et al.
Publicado: (2015)

Quantification of tumour heterogeneity and glucose metabolism on pre-chemoradiation PET/CT predicts survival in anal cancer
por: Afaq, A, et al.
Publicado: (2015)

Functional genomics of lung cancer progression reveals mechanism of metastasis suppressor function
por: Thakur, Ram Krishna, et al.
Publicado: (2014)

Network meetings – access to specialist knowledge and mediation of social support for patients with primary brain tumours and their families – a participatory action research project
por: Olsen, Pia Riis
Publicado: (2015)

S76. Adoptive cell therapy of melanoma with autologous tumour infiltrating lymphocytes
por: Svane, I, et al.
Publicado: (2014)

S6. Proffered paper: Anti-tumour immunomodulatory activity of heat shock protein Hsp70 in therapy of malignant brain tumours: preclinical and clinical data
por: Shevtsov, M, et al.
Publicado: (2014)

First Line Therapy in 2014
por: Nelson, Mark
Publicado: (2014)

What is the extent, range and nature of evidence available around the impact of 12-hour nursing shift patterns?
por: Harris, Ruth
Publicado: (2015)

Gene therapy and bone marrow transplantation
por: Van Lunzen, Jan
Publicado: (2014)

Perspective of stem cell research & therapy in diabetes
por: Gupta, Sarita
Publicado: (2014)

Enzyme replacement therapy for lysosomal storage disorders in India
por: Muranjan, Mamta
Publicado: (2014)

S79. CAR strategies in solid tumours
por: Rossig, C
Publicado: (2014)

Evolution of resistance to MAPK-targeted therapies
por: Lo, Roger
Publicado: (2015)

Assessing emotional health needs of patients with schizophrenia in order to apply more effective therapies to improve their quality of life
por: Molina, Andrea Mallorquí, et al.
Publicado: (2015)

Angiogenesis and hypoxia in lymph node metastases is predicted by the angiogenesis and hypoxia in the primary tumour in patients with breast cancer
por: Van den Eynden, G G, et al.
Publicado: (2005)

Mutational landscape of gingivo-buccal oral cancer: new cancer genes and molecular subgroups identified
por: Majumder, Partha P
Publicado: (2014)

S50. Proffered paper: Complex tumour microenvironment screening platform captures biological responses of cancer therapeutics
por: Layman, H, et al.
Publicado: (2014)

S47. Tumour infiltrating lymphocytes - a predictive marker?
por: Galon, J
Publicado: (2014)

Unlocking the chemistry of bile acids for cancer therapeutics
por: Bajaj, Avinash
Publicado: (2014)

In search of epi-driver genes in head and neck cancer
por: Bhattacharjya, Sumana, et al.
Publicado: (2014)

An empirical assay for assessing genomic sensitivity and for improving cancer diagnostics
por: Anderson, Diana
Publicado: (2014)

Comparison of standard staging protocol and WB-MRI for initial staging of rectal cancer
por: Yoon, JH, et al.
Publicado: (2015)

CT texture analysis as a prognostic marker in metastatic colorectal cancer patients treated with bevacizumab
por: Chen, Shih-Hsin, et al.
Publicado: (2015)

Epigenetic regulation of double c2 like domain beta (Doc2b) in cervical cancer
por: Satyamoorthy, K, et al.
Publicado: (2014)

Pre-treatment ADC histogram-analysis at whole body diffusion-weighted MRI predicts disease free survival in ovarian cancer
por: Michielsen, K, et al.
Publicado: (2015)

S38. Many reasons for combining immunotherapy with chemotherapy to enhance anti tumour response
por: Dalgleish, A, et al.
Publicado: (2014)

Genetic heterogeneity and transcriptional plasticity drive resistance during immunotherapy and targeted therapy
por: Dummer, Reinard
Publicado: (2015)

Advances in adoptive cellular therapy of cancer
por: Stroncek, David
Publicado: (2015)

S2. Therapeutic strategies based on overcoming immune resistance mechanisms within the melanoma tumour microenvironment
por: Gajewski, T
Publicado: (2014)

S35. Investigating the ICOS/ICOSL pathway as a target for combination therapy with anti-CTLA-4
por: Sharma, P
Publicado: (2014)

Involvement of the ocular system in hypohidrotic ectodermal dysplasia
por: Kaercher, Thomas
Publicado: (2012)

PReS13-SPK-1586: Biological agents for the treatment of rheumatic diseases: present and future targets of biologic therapy
por: Mcinnes, I
Publicado: (2013)

Emerging CNS involvement in FAP-TTR long survival patients
por: Maia, Luisa
Publicado: (2015)

S41. Novel CEA-targeted IL2 variant immunocytokine for immunotherapy of cancer
por: Klein, C
Publicado: (2014)

S9. Proffered paper: Identification of novel immune checkpoints as targets for cancer immunotherapy
por: Cojocaru, G, et al.
Publicado: (2014)

Prenatal screening for Mendelian disorders in antenatal care
por: Verma, Amar
Publicado: (2014)

Newborn screening- the roadmap for India
por: Kapoor, Seema
Publicado: (2014)

Non-coding RNA based regulation of blood vessel development in zebrafish and relevance to humans
por: Sivasubbu, Sridhar
Publicado: (2014)

Digital health, microfluidics, and bedside genetic testing
por: Hashsham, Syed
Publicado: (2014)

Genomic packaging and epigenetic regulation of genes
por: Mishra, Rakesh
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_7leo00d6kcd702sufmjdluh66e